These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1317 related items for PubMed ID: 28916432

  • 1. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J, Troilo A, Salzer U, Schleyer T, Halmschlag K, Rizzi M, Frede N, Venhoff A, Voll RE, Venhoff N.
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [Abstract] [Full Text] [Related]

  • 2. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Thiel J, Hässler F, Salzer U, Voll RE, Venhoff N.
    Arthritis Res Ther; 2013 Sep 24; 15(5):R133. PubMed ID: 24286362
    [Abstract] [Full Text] [Related]

  • 3. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
    Casal Moura M, Berti A, Keogh KA, Volcheck GW, Specks U, Baqir M.
    Clin Rheumatol; 2020 May 24; 39(5):1581-1590. PubMed ID: 31897956
    [Abstract] [Full Text] [Related]

  • 4. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry MJ, Amudala N, Smith R, Sivasothy P, Guillevin L, Merkel PA, Jayne DR.
    Ann Rheum Dis; 2016 Feb 24; 75(2):396-401. PubMed ID: 25467294
    [Abstract] [Full Text] [Related]

  • 5. Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence.
    Fanouriakis A, Kougkas N, Vassilopoulos D, Fragouli E, Repa A, Sidiropoulos P.
    Semin Arthritis Rheum; 2015 Aug 24; 45(1):60-6. PubMed ID: 25908179
    [Abstract] [Full Text] [Related]

  • 6. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H, Lee SM, Manno RL, Seo P, Geetha D.
    Semin Arthritis Rheum; 2015 Aug 24; 45(1):67-9. PubMed ID: 25796088
    [Abstract] [Full Text] [Related]

  • 7. Novel Therapies for ANCA-associated Vasculitis.
    Monti S, Brandolino F, Milanesi A, Xoxi B, Delvino P, Montecucco C.
    Curr Rheumatol Rep; 2021 Apr 28; 23(6):38. PubMed ID: 33909172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F, Alberici F, Oliva E, Urban ML, Palmisano A, Santarsia F, Andrulli S, Pavone L, Pesci A, Grasselli C, Santi R, Tumiati B, Manenti L, Buzio C, Vaglio A.
    PLoS One; 2017 Apr 28; 12(10):e0185880. PubMed ID: 29016646
    [Abstract] [Full Text] [Related]

  • 11. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
    Bouiller K, Samson M, Eicher JC, Audia S, Berthier S, Leguy V, Humbert O, Martin L, Lorgis L, Cottin Y, Bonnotte B, Lorcerie B.
    Intern Med J; 2014 Sep 28; 44(9):928-31. PubMed ID: 25201426
    [Abstract] [Full Text] [Related]

  • 12. Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
    Pagnoux C, Groh M.
    Expert Rev Clin Immunol; 2016 Oct 28; 12(10):1059-67. PubMed ID: 27191665
    [Abstract] [Full Text] [Related]

  • 13. Churg-Strauss syndrome.
    Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, Altissimi G, De Vincentiis M.
    Autoimmun Rev; 2015 Apr 28; 14(4):341-8. PubMed ID: 25500434
    [Abstract] [Full Text] [Related]

  • 14. B-cell-targeted therapy in systemic vasculitis.
    Lally L, Spiera R.
    Curr Opin Rheumatol; 2016 Jan 28; 28(1):15-20. PubMed ID: 26599379
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of conventional immunosuppressants in relapsing or refractory eosinophilic granulomatosis with polyangiitis: evidence from a Canadian single-centre cohort.
    Doubelt I, Pulenzas N, Carette S, Pagnoux C, Canadian Vasculitis Network (CanVasc).
    Clin Exp Rheumatol; 2020 Jan 28; 38 Suppl 124(2):171-175. PubMed ID: 32167871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S, Gundappa C, Gandhi A, Kurien AA, Fernando E.
    Saudi J Kidney Dis Transpl; 2017 Jan 28; 28(3):639-644. PubMed ID: 28540906
    [Abstract] [Full Text] [Related]

  • 20. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
    Cartin-Ceba R, Fervenza FC, Specks U.
    Curr Opin Rheumatol; 2012 Jan 28; 24(1):15-23. PubMed ID: 22089095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.